AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Worldwide Chemotherapy Drugs Market Outlook to 2023 - Featuring Pfizer, Eli Lilly, Celgene, Bristol-Myers Squibb, Merck & Co, GlaxoSmithKline, Novartis, Sanofi, and Teva Pharmaceutical Industries - ResearchAndMarkets.com

April 19, 2019

DUBLIN--(BUSINESS WIRE)--Apr 19, 2019--The “Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)” report has been added to ResearchAndMarkets.com’s offering.

The report analyzes the Chemotherapy Drugs Market for the historical period of 2013-2017 and the forecast period of 2018-2023. According to the report, the market is projected to display a robust growth represented by a CAGR of 11.91% during 2018-2023.

On the basis of type of chemotherapy drug, plant alkaloids and antitumor antibiotics have been witnessing growth at a noteworthy rate over the past few years backed by effective use of these medications for the treatment of several varieties of cancers such as breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumors, etc.

Amongst the regions, North America accounts for the largest regional share in the global chemotherapy drugs market in 2018. However, in the forecast period, the Asia Pacific region is anticipated to advance at the highest pace. Key factors driving the robust growth rate of Asia Pacific region include boosting production of pharmaceuticals, growing incidence of cancer along with government’s focus on medical infrastructural developments.

Scope of the Report

Global Chemotherapy Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023

  • Global Chemotherapy Drugs Market - Size, Growth, Forecast
  • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
  • By Route of Administration (Oral, Intravenous, Others)

Regional Markets - North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)

  • Regional Chemotherapy Drugs Market - Size, Growth, Forecast
  • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
  • By Route of Administration (Oral, Intravenous, Others)

Country Analysis - U.S, Canada, United Kingdom, Germany, China and India (Actual Period: 2013-2017, Forecast Period: 2018-2023)

  • Chemotherapy Drugs Market - Size, Growth, Forecast
  • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
  • By Route of Administration (Oral, Intravenous, Others)

Other Report Highlights

  • Market Dynamics - Drivers and Restraints
  • Market Trends
  • SWOT Analysis
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape
  • Company Analysis - Pfizer, Eli Lilly & Company, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Novartis, Sanofi, Teva Pharmaceutical Industries Limited

Key Topics Covered

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Chemotherapy Drugs Market Outlook

5. Global Chemotherapy Drugs Market: Growth and Forecast

5.1 By Value (2013-2017)

5.2 By Value (2018-2023)

6. Global Chemotherapy Drugs Market: Segment Analysis

6.1 Global Antimetabolite Chemotherapy Drugs Market, By Value (2013-2023)

6.2 Global Plant Alkaloid Chemotherapy Drugs Market, By Value (2013-2023)

6.3 Global Antitumor Antibiotic Chemotherapy Drugs Market, By Value (2013-2023)

6.4 Other Chemotherapy Drugs Market, By Value (2013-2023)

6.5 Global Chemotherapy Drugs Market Size, By Route of Administration: Breakdown (%)

6.5.1 Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)

6.5.2 Global Chemotherapy Drugs Market Size, By Route of Administration, 2023 (%)

6.6 Global Intravenous Chemotherapy Drugs Market, By Value (2013-2023)

6.6 Global Oral Chemotherapy Drugs Market, By Value (2013-2023)

6.7 Other Chemotherapy Drugs Market, By Value (2013-2023)

7. Global Chemotherapy Drugs Market: Regional Analysis

7.1 Global Chemotherapy Drugs Market Size, By Region: Breakdown (%)

7.2 North America Chemotherapy Drugs Market: Growth and Forecast

7.3 North America Chemotherapy Drugs Market: Country Analysis (U.S and Canada)

7.4 Europe Chemotherapy Drugs Market: Growth and Forecast

7.5 Europe Chemotherapy Drugs Market: Country Analysis (Germany and U.K)

7.6 APAC Chemotherapy Drugs Market: Growth and Forecast

7.7 APAC Chemotherapy Drugs Market: Country Analysis (India and China)

7.8 ROW Chemotherapy Drugs Market: Growth and Forecast

8. Global Chemotherapy Drugs Market Dynamics

8.1 Global Chemotherapy Drugs Market Drivers

8.2 Global Chemotherapy Drugs Market Restraints

9. Global Chemotherapy Drugs Market Trends

10. Porter Five Force Analysis

11. SWOT Analysis

12. Policy and Regulatory Landscape

14. Company Profiles

14.1 Pfizer

14.2 Eli Lilly & Company

14.3 CELGENE Corporation

14.4 Bristol-Myers Squibb

14.5 Merck & Co. Inc.

14.6 GlaxoSmithKline PLC

14.7 Novartis

14.8 Sanofi

14.9 Teva Pharmaceuticals Industries Limited

For more information about this report visit https://www.researchandmarkets.com/r/sghees

View source version on businesswire.com:https://www.businesswire.com/news/home/20190419005042/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 04/19/2019 05:28 AM/DISC: 04/19/2019 05:27 AM

http://www.businesswire.com/news/home/20190419005042/en

All contents © copyright 2019 The Associated Press.All rights reserved.